Digital pathology added to DICOM standards

TriMed Staff | | Health Exec | EMR/EHR

The College of American Pathologists (CAP) has contributed to the expansion of the Digital Imaging and Communications in Medicine (DICOM) medical image exchange standard, Supplement 145, for the accommodation of pathology.

Supplement 145, the new standard for "Whole Microscopic Images," will enable electronic display, sharing, storage and management of larger images usually associated with pathology, and will facilitate health information interoperability of pathology medical images, various whole slide imaging equipment manufacturers, PACS and EHRs, according to CAP.

TriMed Staff

Related Content

Gottlieb: Let’s not slap the label ‘medical device’ on AI software that only helps clinicians make care decisions
PHOTO GALLERY: The Epic intergalactic headquarters art collection
AI brings cardiology, neurology teams together to boost care for stroke patients
Best in KLAS: End-users review top health IT systems in the US
More than words: AI takes NLP to the next level to identify signs of heart failure
Christmas ransomware exposed over 300K patient records to dark web

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”